MedTrace Logo

Moderate Intensity Training in Patients With Truncating Genetic Variants in TTN.

NCT05180188 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 14

Last updated 2022-11-22

No results posted yet for this study

Summary

The aim is to investigate the effect of an 8-week moderate-intensity exercise program on aerobic fitness and cardiac contractility in patients with truncations of the sarcomeric protein titin.

Conditions

  • Cardiomyopathies
  • Truncation Mutation
  • TTN

Interventions

BEHAVIORAL

Training

In the 8-week training period, participants will have three training sessions with a duration of 30 minutes at 70% of VO2peak per week.

Sponsors & Collaborators

  • Rigshospitalet, Denmark

    lead OTHER

Principal Investigators

  • John Vissing, MD PhD · Rigshospitalet, Denmark

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-02-14
Primary Completion
2022-09-21
Completion
2022-09-21

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05180188 on ClinicalTrials.gov